Trial Profile
Double blind, randomized, parallel group, pilot study of oral dronabinol versus placebo in the treatment or prevention of highly active antiretroviral therapy related nausea and vomiting
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Apr 2010
Price :
$35
*
At a glance
- Drugs Dronabinol (Primary)
- Indications Nausea and vomiting
- Focus Therapeutic Use
- Sponsors Solvay Pharmaceuticals
- 09 Apr 2008 New trial record.